Business Description
X4 Pharmaceuticals is a Boston-based drug development company focused on creating treatments for rare immune system disorders. Its main product, XOLREMDI, is a pill that targets a specific protein receptor in the body and is being tested in late-stage clinical trials for a condition that leaves patients vulnerable to serious infections. The company has partnered with several organizations to bring its treatments to patients across Asia, Europe, Australia, and New Zealand.
